EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Apoptotic Vesicles Modulate Endothelial Metabolism and Ameliorate Ischemic Retinopathy via PD1/PDL1 Axis

Yutong Jing, Wanmin Zhao, Ziyi Zhou, Wenzhe Wang, Yali Niu, Xiaoning He, Tianfang Chang, Changmei Guo, Bei Li, Guorui Dou iD

Advanced Healthcare Materials · 2024-07 · 13 (17)

DOI: 10.1002/adhm.202303527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.03.2024. Verfasst von Yutong Jing und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Hauptthemen laut MEDLINE: Apoptosis, Extracellular Vesicles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shaanxi Natural Science Basic Research Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathological angiogenesis with subsequent disturbed microvascular remodeling is a major cause of irreversible blindness in a number of ischemic retinal diseases. The current anti‐vascular endothelial growth factor therapy can effectively inhibit angiogenesis, but it also brings significant side effects. The emergence of stem cell derived extracellular vesicles provides a new underlining strategy for ischemic retinopathy. Apoptotic vesicles (apoVs) are extracted from stem cells from human exfoliated deciduous teeth (SHED). SHED‐apoVs are delivered into the eyeballs of oxygen‐induced retinopathy (a most common model of angiogenic retinal dieseases) mice through intravitreal injection. The retinal neovascularization and nonperfusion area, vascular structure, and density changes are observed during the neovascularization phase (P17) and vascular remodeling phase (P21), and visual function is measured. The expression of extracellular acidification rate and lactic acid testing are used to detect endothelial cells (ECs) glycolytic activity. Furthermore, lentivirus and neutralizing antibody are used to block PD1‐PDL1 axis, investigating the effects of SHED‐apoVs on glycolysis and angiogenic activities. This work shows that SHED‐apoVs are taken up by ECs and modulate the ECs glycolysis, leading to the decrease of abnormal neovessels and vascular remodeling. Furthermore, it is found that, at the molecular level, apoVs‐carried PD1 interacts with PDL1 on hypoxic ECs to regulate the angiogenic activation. SHED‐apoVs inhibit pathological angiogenesis and promote vascular remodeling in ischemic retinopathy partially by modulating ECs glycolysis through PD1/PDL1 axis. This study provides a new potential strategy for the clinical treatment of pathological retinal neovascularization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisExtracellular VesiclesAnimalsHumansMiceEndothelial CellsB7-H1 AntigenIschemiaRetinal NeovascularizationProgrammed Cell Death 1 ReceptorGlycolysisRetinal DiseasesMice, Inbred C57BL

Stichwörter der Autor:innen

PD1/PDL1 axisapoptotic vesiclesglycolysis, ischemic retinopathystem cells from human exfoliated deciduous teeth

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
  • State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Disease, Shaanxi International Joint Research Center for Oral Diseases, Center for Tissue Engine…

ORCID-Profile: Guorui Dou

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shaanxi Natural Science Basic Research Key Project

Zitieren

APA

Jing, Y., Zhao, W., Zhou, Z., Wang, W., Niu, Y., He, X., Chang, T., Guo, C., Li, B., & Dou, G. (2024). Apoptotic Vesicles Modulate Endothelial Metabolism and Ameliorate Ischemic Retinopathy via PD1/PDL1 Axis. Advanced Healthcare Materials, 13(17). https://doi.org/10.1002/adhm.202303527

Vancouver

Jing Y, Zhao W, Zhou Z, Wang W, Niu Y, He X, et al. Apoptotic Vesicles Modulate Endothelial Metabolism and Ameliorate Ischemic Retinopathy via PD1/PDL1 Axis. Advanced Healthcare Materials. 2024;13(17). doi:10.1002/adhm.202303527

BibTeX
@article{Jing2024,
  author = {Jing, Yutong and Zhao, Wanmin and Zhou, Ziyi and Wang, Wenzhe and Niu, Yali and He, Xiaoning and Chang, Tianfang and Guo, Changmei and Li, Bei and Dou, Guorui},
  title = {Apoptotic Vesicles Modulate Endothelial Metabolism and Ameliorate Ischemic Retinopathy via PD1/PDL1 Axis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {17},
  doi = {10.1002/adhm.202303527}
}
Kostenlos starten →